{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:28Z","timestamp":1787028568833,"version":"build-2736575974"},"reference-count":202,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council (CSC)","doi-asserted-by":"publisher","award":["202008520048"],"award-info":[{"award-number":["202008520048"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human fungal infections comprise systemic mycoses as well as various skin diseases. Rising case numbers along with inefficient therapies and the appearance of drug-resistant strains unleashed a considerable health problem over the last years. Thus, the identification and development of new antifungal drugs is mandatory, which can include the design of new antifungals, or, more time saving, the repurposing of known drugs already applied for the therapy of other human diseases. The orally applicable gold-based drug auranofin has been used for the treatment of rheumatoid arthritis since the 1980s. However, auranofin also showed marked activity against various cancers, microbes, parasites, and viruses. Facing a pressing need to find new drug candidates against mycoses, especially against those listed in the WHO fungal pathogen priority list, we have summarized the eminent antifungal activities of auranofin in this review. Given its established safety profile and broad-spectrum activity, auranofin represents a promising candidate for repurposing in antifungal therapy. The mechanism of action of auranofin was correlated with thioredoxin reductase inhibition, but other modes of action such as interference with mitochondrial protein import and NADH kinase were also described and discussed. A selection of promising antifungal gold complexes was also provided. Pertinent literature is covered until 2025.<\/jats:p>","DOI":"10.3390\/ijms26167909","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:22:33Z","timestamp":1755534153000},"page":"7909","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin"],"prefix":"10.3390","volume":"26","author":[{"given":"Jingyi","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"van de Sande","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-346X","authenticated-orcid":false,"given":"Bernhard","family":"Biersack","sequence":"additional","affiliation":[{"name":"Organic Chemistry Laboratory, University of Bayreuth, Universit\u00e4tsstrasse 30, 95440 Bayreuth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: The silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Fahal","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4236\/pp.2024.154007","article-title":"Global burden of fungal infections and antifungal resistance from 1961 to 2024: Findings and future implications","volume":"15","author":"Mudenda","year":"2024","journal-title":"Pharmacol. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Carmo, A., Rocha, M., Pereirinha, P., Tom\u00e9, R., and Costa, E. (2023). Antifungals: From pharmacokinetics to clinical practice. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050884"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rodrigues, M.L., and Nosanchuk, J.D. (2020). Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007964"},{"key":"ref_8","unstructured":"(2025, April 03). Mycetoma. Available online: https:\/\/dndi.org\/diseases\/mycetoma\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/acsbiomedchemau.2c00055","article-title":"Antifungal development and the urgency of minimizing the impact of fungal diseases on public health","volume":"3","author":"Bezerra","year":"2023","journal-title":"ACS Bio. Med. Chem. Au"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rouges, C., Asad, M., Laurent, A.D., Marchand, P., and Le Pape, P. (2023). Is the C-terminal domain an effective and selective target for the design of Hsp90 inhibitors against Candida yeast?. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122837"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105418","DOI":"10.1016\/j.micpath.2022.105418","article-title":"An insight into the role of protein kinases as virulent factors, regulating pathogenic attributes in Candida albicans","volume":"164","author":"Das","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: What brings the future?","volume":"57","author":"Spriet","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gintjee, T.J., Donnelley, M.A., and Thompson III, G.R. (2020). Aspiring antifungals: Review of current antifungal pipeline developments. J. Fungi, 6.","DOI":"10.3390\/jof6010028"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2022.2097659","article-title":"Novel avenues for identification of new antifungal drugs and current challenges","volume":"17","author":"Jampilek","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1021\/acs.jmedchem.4c02084","article-title":"Redefining antifungal treatment: The innovation of metal-based compounds","volume":"68","author":"Cardoso","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijge.2011.09.015","article-title":"Application of gold in biomedicine: Past, present and future","volume":"6","author":"Wang","year":"2012","journal-title":"Int. J. Gerontol."},{"key":"ref_17","first-page":"52","article-title":"Use of gold in human health and diseases: Research updates","volume":"6","author":"Sinha","year":"2018","journal-title":"J. Ayurveda Holist. Med."},{"key":"ref_18","first-page":"000325","article-title":"Suvarnaprashan: An Ayurvedic immune booster","volume":"5","author":"Meena","year":"2021","journal-title":"Nat. Ayurvedic Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF03214618","article-title":"Gold in medicine: A review of its use in the West before 1900","volume":"15","author":"Higby","year":"1982","journal-title":"Gold Bull."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/ed066p631","article-title":"Ancient and medieval Chinese protochemistry: The earliest examples of applied inorganic chemistry","volume":"66","author":"Glidewell","year":"1989","journal-title":"J. Chem. Educ."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kaim, W., and Schwederski, B. (1995). Bioanorganische Chemie, B.G. Teubner. [2nd ed.].","DOI":"10.1007\/978-3-322-91893-2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1002\/chem.202101028","article-title":"Cooperative ligands in dissolution of gold","volume":"27","author":"Liljeqvist","year":"2021","journal-title":"Chem. Eur. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e202214453","DOI":"10.1002\/anie.202214453","article-title":"Sustainable and selective modern methods of noble metal recycling","volume":"62","author":"Zupanc","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10787-007-0021-x","article-title":"Clinical pharmacology of gold","volume":"16","author":"Kean","year":"2008","journal-title":"Inflammopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/thx.35.12.884","article-title":"The gold rush 1925\u201335","volume":"35","author":"Keers","year":"1980","journal-title":"Thorax"},{"key":"ref_26","first-page":"232","article-title":"L\u2019Auroth\u00e9rapie dans les rhumatismes chroniques","volume":"54","author":"Forestier","year":"1929","journal-title":"Ann. Med. Interne"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(00)82169-8","article-title":"Rheumatoid arthritis and its treatment by gold salts","volume":"224","author":"Forestier","year":"1934","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/cr980431o","article-title":"Gold-based therapeutic agents","volume":"99","author":"Shaw","year":"1999","journal-title":"Chem. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.2174\/092986712802002482","article-title":"Coinage metal complexes against breast cancer","volume":"19","author":"Biersack","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22639","DOI":"10.1073\/pnas.2007285117","article-title":"Gold-based therapy: From past to present","volume":"117","author":"Balfourier","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/jm00281a001","article-title":"Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes","volume":"15","author":"Sutton","year":"1972","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: Repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108272","DOI":"10.1016\/j.intimp.2021.108272","article-title":"Auranofin: Past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"216208","DOI":"10.1016\/j.ccr.2024.216208","article-title":"Functional utility of gold complexes with phosphorus donor ligands in biological systems","volume":"522","author":"Arojojoye","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_36","first-page":"1","article-title":"Auranofin and its analogs as prospective agents for the treatment of colorectal cancer","volume":"5","author":"Massai","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Coscione, F., Zineddu, S., Vitali, V., Fondi, M., Messori, L., and Perrin, E. (2024). The many lives of auranofin: How an old anti-rheumatic agent may become a promising antimicrobial drug. Antibiotics, 13.","DOI":"10.3390\/antibiotics13070652"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17568919.2025.2453422","article-title":"The antimicrobial activity of auranofin and other gold complexes","volume":"17","author":"Chen","year":"2025","journal-title":"Future Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sonzogni-Desautels, K., and Ndao, M. (2021). Will auranofin become a golden new treatment against COVID-19?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.683694"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"216408","DOI":"10.1016\/j.ccr.2024.216408","article-title":"Current state of the art of gold complexes as antileishmanial agents","volume":"528","author":"Hemmert","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Feng, L., Pomel, S., de Late, P.L., Taravaud, A., Loiseau, P.M., Maes, L., Cho-Ngwa, F., Bulman, C.A., Fischer, C., and Sakanari, J.A. (2020). Repurposing auranofin and evaluation of a new gold(I) compound for the search of treatment of human and cattle parasitic diseases: From protozoa to helminth infections. Molecules, 25.","DOI":"10.3390\/molecules25215075"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117527","DOI":"10.1016\/j.ejmech.2025.117527","article-title":"Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases","volume":"290","author":"Laila","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","first-page":"9109041","article-title":"Ebselen: A promising repurposing drug to treat infections caused by multidrug-resistant microorganisms","volume":"2024","year":"2024","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e040122199856","DOI":"10.2174\/2211352520666220104104747","article-title":"Disulfiram: A repurposed drug in preclinical and clinical development for the treatment of infectious diseases","volume":"20","author":"Custodio","year":"2022","journal-title":"Anti-Infect. Agents"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"myac016","DOI":"10.1093\/mmy\/myac016","article-title":"Effect of copper on the antifungal activity of disulfiram (Antabuse\u00ae) in fluconazole-resistant Candida strains","volume":"60","author":"Shanholtzer","year":"2022","journal-title":"Med. Mycol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1039\/D5RA00196J","article-title":"Crystal structure and polymorphic forms of auranofin revisited","volume":"15","author":"Ziemniak","year":"2025","journal-title":"RSC Adv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1021\/acs.jmedchem.9b00550","article-title":"Synthesis and structure-activity relationship study of antimicrobial auranofin against ESKAPE pathogens","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_48","unstructured":"Whistler, R.L., Wolfrom, M.L., and BeMiller, J.N. (1963). Reactions of Carbohydrates. Methods in Carbohydrate Chemistry, Academic Press. [2nd ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(25)29206-0","article-title":"SK&F 36914\u2014An agent for oral chrysotherapy","volume":"181","author":"Walz","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1039\/D0DT00283F","article-title":"ESI MS studies highlight the selective interaction of auranofin with protein free thiols","volume":"49","author":"Zoppi","year":"2020","journal-title":"Dalton Trans."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.comptc.2014.09.005","article-title":"Reactivity of auranofin with S-, Se- and N-containing amino acids","volume":"1048","year":"2014","journal-title":"Comput. Theoret. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1021\/ic902335z","article-title":"Seleno-auranofin (Et3PAuSe-tagl): Synthesis, spectroscopic (EXAFS, 197Au M\u00f6ssbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation","volume":"49","author":"Hill","year":"2010","journal-title":"Inorg. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ma, C.I., Tirtorahardjo, J.A., Schweizer, S.S., Zhang, J., Fang, Z., Xing, L., Xu, M., Herman, D.A., Kleinman, M.T., and McCullough, B.S. (2024). Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.02968-23"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","article-title":"Biologic actions and pharmacokinetic studies of auranofin","volume":"75","author":"Walz","year":"1983","journal-title":"Am. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12272-023-01438-1","article-title":"Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1155\/MBD.1994.351","article-title":"Redox chemistry and [Au(CN)2\u2212] in the formation of gold metabolites","volume":"1","author":"Shaw","year":"1994","journal-title":"Met. Based Drugs"},{"key":"ref_57","unstructured":"Schattenkirchner, M., and Muller, W. (1983). Effect of gold compounds on human mononuclear phagocyte function. Modern Aspects of Gold Therapy, Karger."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Yue, S., Luo, M., Liu, H., and Wei, S. (2020). Recent advances of gold compounds in anticancer immunity. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.00543"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/emm.2003.9","article-title":"Gold compound auranofin inhibits I\u03baB kinase (IKK) by modifying Cys-179 of IKK\u03b2 subunit","volume":"35","author":"Jeon","year":"2003","journal-title":"Exp. Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1039\/C6JA00068A","article-title":"HPLC-ICP-MS for simultaneous quantification of the total and active form of the thioredoxin reductase enzyme in human serum using auranofin as an activity-based probe","volume":"31","year":"2016","journal-title":"J. Anal. At. Spectrom."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/ic9414280","article-title":"Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro","volume":"35","author":"Roberts","year":"1996","journal-title":"Inorg. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Dabrowiak, J.C. (2009). Metals in Medicine, John Wiley & Sons.","DOI":"10.1002\/9780470684986"},{"key":"ref_63","first-page":"1","article-title":"A phase Ib\/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3","volume":"3","author":"Halatsch","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijantimicag.2019.08.001","article-title":"Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial","volume":"54","author":"Diaz","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e01947-16","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: A prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"i26","DOI":"10.1093\/jac\/dkx446","article-title":"Tolerability profile of the current antifungal armoury","volume":"73","author":"Mourad","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: A crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ratia, C., Soengas, R.G., and Soto, S.M. (2022). Gold-derived molecules as new antimicrobial agents. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.846959"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-827X(99)00019-1","article-title":"Gold(I) complexes as antimicrobial agents","volume":"54","author":"Novelli","year":"1999","journal-title":"Il Farmaco"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/MBD.1999.271","article-title":"Biologically-active gold(III) complexes","volume":"6","author":"Parish","year":"1999","journal-title":"Met. Based Drugs"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/AAC.00680-13","article-title":"High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors","volume":"57","author":"Siles","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jam.14443","article-title":"Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp. J","volume":"128","author":"She","year":"2020","journal-title":"Appl. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Felix, L.O., Whitely, C., Tharmalingam, N., Mishra, B., Vera-Gonzalez, N., Mylonakis, E., Shukla, A., and Fuchs, B.B. (2023). Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1135942"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/AAC.01087-13","article-title":"Antifungal application of nonantifungal drugs","volume":"58","author":"Stylianou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/fmc.15.182","article-title":"Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin","volume":"8","author":"Fuchs","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Thangamani, S., Maland, M., Mohammad, H., Pascuzzi, P.E., Avramova, L., Koehler, C.M., Hazbun, T.R., and Seleem, M.N. (2017). Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-Erv1 pathway. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00004"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2005.04.011","article-title":"A disulfide relay system in the intermembrane space of mitochondria that mediates protein import","volume":"121","author":"Mesecke","year":"2005","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biocel.2015.05.016","article-title":"Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration","volume":"65","author":"Gamberi","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lin, J., Xiao, X., Liang, Y., Zhao, H., Yu, Y., Yuan, P., Lu, S., and Ding, X. (2022). Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.1065962"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11046-025-00948-4","article-title":"Synergistic antifungal activity of pentamidine and auranofin against multidrug-resistant Candida auris","volume":"190","author":"Retore","year":"2025","journal-title":"Mycopathologia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e01921-19","DOI":"10.1128\/AAC.01921-19","article-title":"Identification of off-patent drugs that show synergism with amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp. Antimicrob","volume":"64","author":"Rossi","year":"2020","journal-title":"Agents Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101381","DOI":"10.1016\/j.mycmed.2023.101381","article-title":"In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus","volume":"33","author":"Chen","year":"2023","journal-title":"J. Mycol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e00034-23","DOI":"10.1128\/cmr.00034-23","article-title":"An updated list of eumycetoma causative agents and their differences in grain formation and treatment response","volume":"37","author":"Fahal","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hao, X., Cognetii, M., Burch-Smith, R., O\u2019Sullivan Mejia, E., and Mirkin, G. (2022). Mycetoma: Development of diagnosis and treatment. J. Fungi, 8.","DOI":"10.3390\/jof8070743"},{"key":"ref_87","unstructured":"(2025, April 12). Mycetoma Open Source\/MycetOS. Available online: https:\/\/github.com\/OpenSourceMycetoma."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"106205","DOI":"10.1016\/j.actatropica.2021.106205","article-title":"The developed molecular biological identification tools for mycetoma causative agents: An update","volume":"225","author":"Siddig","year":"2022","journal-title":"Acta Trop."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sampaio, F.M.S., Wanke, B., Freitas, D.F.S., Coelho, J.M.C.d.O., Galhardo, M.C.G., Lyra, M.R., Louren\u00e7o, M.C.d.S., Paes, R.d.A., and do Valle, A.C.F. (2017). Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005301"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S0036-46652013000200010","article-title":"Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: Report of a case and review of the Brazilian reports on scedosporiosis","volume":"55","author":"Oliveira","year":"2013","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_91","first-page":"881","article-title":"Histoplasmosis outbreaks in Brazil: Lessons to learn about preventing exposure","volume":"185","author":"Guerra","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007016414833","article-title":"Chronic pulmonary histoplasmosis in the state of Rio de Janeiro, Brazil","volume":"145","author":"Capone","year":"1999","journal-title":"Mycopathologia"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Almeida, M.d.A., Baeza, L.C., Silva, L.B.R., Bernardes-Engemann, A.R., Almeida-Silva, F., Coelho, R.A., de Andrade, I.B., Correa-Junior, D., Frases, S., and Zancop\u00e9-Oliveira, R.M. (2024). Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012586"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Rollin-Pinheiro, R., Borba-Santos, L.P., da Silva Xisto, M.I.D., de Castro-Almeida, Y., Rochetti, V.P., Rozental, S., and Barreto-Bergter, E. (2021). Identification of promising antifungal drugs against Scedosporium and Lomentospora species after screening of Pathogen Box library. J. Fungi, 7.","DOI":"10.3390\/jof7100803"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1080\/21505594.2021.1909266","article-title":"Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans","volume":"12","author":"Yaakoub","year":"2021","journal-title":"Virulence"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Sun, L., Liao, K., and Wang, D. (2017). Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicans. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184003"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Santos","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Coelho, R.A., Joffe, L.S., Alves, G.M., Figueiredo-Carvalho, M.H.G., Brito-Santos, F., Amaral, A.C.F., Rodrigues, M.L., and Almeida-Paes, R. (2020). A screening of the MMV Pathogen Box\u00ae reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis. PLoS ONE, 15.","DOI":"10.1101\/2020.02.12.945378"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e00205-25","DOI":"10.1128\/mbio.00205-25","article-title":"Discovery of novel antifungal drugs via screening repurposing libraries against Coccidioides posadasii spherule initials","volume":"16","author":"Saeger","year":"2025","journal-title":"mBio"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, N., Grimshaw, A.A., Axson, S.A., Choe, S.H., and Miller, J.E. (2022). Drug repurposing: A systematic review on root causes, barriers and facilitators. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-08272-z"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1007\/s13346-024-01719-2","article-title":"Auranofin loaded silk fibroin nanoparticles for colorectal cancer treatment","volume":"15","author":"Reidy","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10534-021-00313-0","article-title":"Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA-PEG nanoparticles","volume":"34","author":"Menconi","year":"2021","journal-title":"Biometals"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1007\/s00210-024-03253-x","article-title":"Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: Modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters","volume":"397","author":"Kushawaha","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2174\/0113816128336703241202182209","article-title":"Auranofin-loaded PLGA nanoparticles for neuroprotection against aluminium-induced Alzheimer\u2019s disease","volume":"31","author":"Kushawaha","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1900157","DOI":"10.1002\/adtp.201900157","article-title":"Composite thermoresponsive hydrogel with auranofin-loaded nanoparticles for topical treatment of vaginal trichomonad infection","volume":"2","author":"Zhang","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Picheta, N., Piekarz, J., Burdan, O., Satora, M., Tarkowski, R., and Ku\u0142ak, K. (2024). Phytotherapy of vulvovaginal candidiasis: A narrative review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073796"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.33393\/dti.2024.3019","article-title":"The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: Analysis based on three major fields","volume":"18","author":"Natsheh","year":"2024","journal-title":"Drug Target Insights"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e0158423","DOI":"10.1128\/aac.01584-23","article-title":"Outcomes by Candida spp. in the ReSTORE phase 3 trial of rezafungin versus caspofungin for candidemia and\/or invasive candidiasis","volume":"68","author":"Locke","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: Fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Ni\u00f1o-Vega, G.A., Padr\u00f3-Villegas, L., and L\u00f3pez-Romero, E. (2024). New ground in antifungal discovery and therapy for invasive fungal infections: Innovations, challenges, and future directions. J. Fungi, 10.","DOI":"10.3390\/jof10120871"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2010.03.083","article-title":"Thioredoxin and thioredoxin reductase: Current research with special reference to human disease","volume":"396","author":"Holmgren","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"17045","DOI":"10.1074\/jbc.272.27.17045","article-title":"Thioredoxin reductase-dependent inhibition of MCB cell cycle box activity in Saccharomyces cerevisiae","volume":"272","author":"Machado","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1074\/jbc.273.10.5431","article-title":"Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression","volume":"273","author":"Pearson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"May, H.C., Yu, J.-J., Guentzel, M.N., Chambers, J.P., Cap, A.P., and Arulanandam, B.P. (2018). Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00336"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Abadio, A.K.R., Kioshima, E.S., Teixeira, M.M., Martins, N.F., Maigret, B., and Felipe, M.S.S. (2011). Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-75"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/EC.4.2.487-489.2005","article-title":"Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans","volume":"4","author":"Misall","year":"2005","journal-title":"Eukaryiot. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e02334-14","DOI":"10.1128\/mBio.02334-14","article-title":"Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization","volume":"6","author":"Ianiri","year":"2015","journal-title":"mBio"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Abadio, A.K.R., Kioshima, E.S., Leroux, V., Martins, N.F., Maigret, B., and Felipe, M.S.S. (2015). Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides genus. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142926"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Binder, J., Shadkchan, Y., Osherov, N., and Krappmann, S. (2020). The essential thioredoxin reductase of the human pathogenic mold Aspergillus fumigatus is a promising antifungal target. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01383"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/pmic.200701097","article-title":"Candida albicans biofilm formation is associated with increased anti-oxidative capacities","volume":"8","author":"Seneviratne","year":"2008","journal-title":"Proteomics"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"15386","DOI":"10.1080\/07391102.2023.2188960","article-title":"Waste to drugs: Identification of pyrolysis by-products as antifungal agents against Cryptococcus neoformans","volume":"41","author":"Krishnan","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e02281-18","DOI":"10.1128\/AAC.02281-18","article-title":"Structure, mechanism, and inhibition of Aspergillus fumigatus thioredoxin reductase","volume":"63","author":"Marshall","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/exd.12257","article-title":"Gentian violet: A 19th century drug re-emerges in the 21st century","volume":"22","author":"Maley","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"de Oliveira, F.F.M., Paredes, V., de Sousa, H.R., Moura, A.N.D.\u00c1., Riasco-Palacios, J., Casadevall, A., Felipe, M.S.S., and Nicola, A.M. (2020). Thioredoxin reductase 1 is a highly immunogenic cell surface antigen in Paracoccidioides spp., Candida albicans, and Cryptococcus neoformans. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02930"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human placenta thioredoxin reductase","volume":"273","author":"Gromer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.tiv.2006.01.012","article-title":"Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)","volume":"20","author":"Omata","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exphem.2014.10.004","article-title":"Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: A novel synergistic therapeutic approach","volume":"43","author":"Kiebala","year":"2015","journal-title":"Exp. Hematol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.redox.2016.01.007","article-title":"Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma","volume":"8","author":"Raninga","year":"2016","journal-title":"Redox Biol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Liu, C., Liu, Z., Li, M., Li, X., Wong, Y.-S., Ngai, S.-M., Zheng, W., Zhang, Y., and Chen, T. (2013). Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocysteine, a synergistic inhibitor of thioredoxin reductase. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053945"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3724\/abbs.2024155","article-title":"Unveiling the cytotoxicity of a new gold(I) complex towards hepatocellular carcinoma by inhibiting TrxR activity","volume":"56","author":"Wang","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00775-022-01968-x","article-title":"Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors","volume":"27","author":"Kober","year":"2022","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Giorgi, E., Mannelli, M., Gamberi, T., Durante, M., Gabbiani, C., Cirri, D., and Pratesi, A. (2024). Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity. J. Inorg. Biochem., 251.","DOI":"10.1016\/j.jinorgbio.2023.112452"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Thangamani, S., Mohammad, H., Abushahba, M.F.N., Sobreira, T.J.P., Hedrick, V.E., Paul, L.N., and Seleem, M.N. (2016). Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci. Rep., 6.","DOI":"10.1038\/srep22571"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Alves, R., and Gourlay, C.W. (2024). Editorial: Mitochondrial function and dysfunction in pathogenic fungi. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1506684"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1074\/jbc.R111.270678","article-title":"Mitochondrial disulfide relay: Redox-regulated protein import into the intermembrane space","volume":"287","author":"Herrmann","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1038\/ncomms4041","article-title":"Mia40 targets cysteines in a hydrophobic environment to direct oxidative protein folding in the mitochondria","volume":"5","author":"Koch","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/cb500408n","article-title":"Mia40 is optimized for function in mitochondrial oxidative protein folding and import","volume":"9","author":"Koch","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Olewewe, C., and Awuah, S.G. (2023). Mitochondria as a target of third row transition metal-based anticancer complexes. Curr. Opin. Chem. Biol., 72.","DOI":"10.1016\/j.cbpa.2022.102235"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/emboj\/cdg211","article-title":"A novel NADH kinase is the mitochondrial source of NADPH in Saccharomyces cerevisiae","volume":"22","author":"Outten","year":"2003","journal-title":"EMBO J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1128\/EC.2.4.809-820.2003","article-title":"POS5 gene of Saccharomyces cerevisiae encodes a mitochondrial NADH kinase required for stability of mitochondrial DNA","volume":"2","author":"Strand","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/abbs\/gmr092","article-title":"Role of mitochondrial NADH kinase and NADPH supply in the respiratory chain activity of Saccharomyces cerevisiae","volume":"43","author":"Shi","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"39409","DOI":"10.1074\/jbc.M110.178947","article-title":"Mitochondrial NADH kinase, Pos5p, is required for efficient iron-sulfur cluster biogenesis in Saccharomyces cerevisiae","volume":"285","author":"Pain","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymben.2023.03.007","article-title":"Rational genome and metabolic engineering of Candida viswanathii by split CRISPR to produce hundred grams of dodecanedioic acid","volume":"77","author":"Pham","year":"2023","journal-title":"Metab. Eng."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Jang, E.-H., Kim, J.-S., Yu, S.-R., and Bahn, Y.-S. (2022). Unraveling capsule biosynthesis and signaling networks in Cryptococcus neoformans. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02866-22"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Biersack, B. (2024). The antifungal potential of niclosamide and structurally related salicylanilides. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115977"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.freeradbiomed.2015.10.421","article-title":"Cu\/Zn-superoxide dismutase and glutathione are involved in response to oxidative stress induced by protein denaturing effect of alachlor in Saccharomyces cerevisiae","volume":"89","author":"Rattanawong","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Tiwari, S., Thakur, R., and Shankar, J. (2015). Role of heat-shock proteins in cellular function and in the biology of fungi. Biotechnol. Res. Int., 2015.","DOI":"10.1155\/2015\/132635"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ancuceanu, R., Hovanet, M.V., Cojocaru-Toma, M., Anghel, A.-I., and Dinu, M. (2022). Potential antifungal targets for Aspergillus sp. from the calcineurin and heat shock protein pathways. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012543"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","article-title":"Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus","volume":"10","author":"Whitesell","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/AAC.00946-15","article-title":"Hsp70 and the cochaperone StiA (Hop) orchestrate Hsp90-mediated caspofungin tolerance in Aspergillus fumigatus","volume":"59","author":"Lamoth","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cstres.2024.05.005","article-title":"An update on the status of HSP90 inhibitors in cancer clinical trials","volume":"29","author":"Rastogi","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Fang, T., Xiong, J., Huang, X., Fang, X., Shen, X., Jiang, Y., and Lu, H. (2025). Extracellular Hsp90 of Candida albicans contributes to the virulence of the pathogen by activating the NF-\u03baB signaling pathway and inducing macrophage pyroptosis. Microbiol. Res., 290.","DOI":"10.1016\/j.micres.2024.127964"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.intimp.2021.108255","article-title":"The triumvirate of NF-kB, inflammation and cytokine storm in COVID-19","volume":"101","author":"Attiq","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3855\/jidc.8062","article-title":"Candida albicans induces TLR2\/MyD88\/NF-\u03baB signaling and inflammation in oral lichen planus-derived keratinocytes","volume":"12","author":"Liu","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Bercusson, A., Williams, T.J., Simmonds, N.J., Alton, E.W., Griesenbach, U., Shah, A., Warris, A., and Armstrong-James, D. (2025). Increased NFAT and NF\u03baB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of Cystic fibrosis. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1012784"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"a019661","DOI":"10.1101\/cshperspect.a019661","article-title":"Fungal pathogens: Survival and replication within macrophages","volume":"5","author":"Gilbert","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Ben-Abdallah, M., Sturny-Lecl\u00e8re, A., Av\u00e9, P., Louise, A., Moyrand, F., Weih, F., Janbon, G., and M\u00e9met, S. (2012). Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-\u03baB. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002555"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"144819","DOI":"10.1016\/j.gene.2020.144819","article-title":"Vitamin D reduces autophagy by regulating NF-\u03baB resistance to Aspergillus fumigatus infection","volume":"753","author":"Hu","year":"2020","journal-title":"Gene"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/bjp.2008.197","article-title":"Auranofin promotes retinoic acid- or dihydroxyvitamin D3-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylation","volume":"154","author":"Park","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4014\/jmb.2207.07017","article-title":"Thymol ameliorates Aspergillus fumigatus keratitis by downregulating TLR4\/MyD88\/NF-kB\/IL-1\u03b2 signal expression and reducing necroptosis and pyroptosis","volume":"33","author":"Wang","year":"2023","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-\u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Folk, A., Cotoraci, C., Balta, C., Suciu, M., Herman, H., Boldura, O.M., Dinescu, S., Paiusan, L., Ardelean, A., and Hermenean, A. (2016). Evaluation of hepatotoxicity with treatment doses of flucytosine and amphotericin B for invasive fungal infections. BioMed Res. Int., 2016.","DOI":"10.1155\/2016\/5398730"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3503912","DOI":"10.1155\/2019\/3503912","article-title":"Auranofin inhibits RANKL-induced osteoclastogenesis by suppressing inhibitors of \u03baB kinase and inflammasome-mediated interleukin-1\u03b2 secretion","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1759720X16671927","article-title":"Bone health in HIV and hepatitis B or C infections","volume":"9","author":"Biver","year":"2017","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Gamaletsou, M.N., Rammaert, B., Brause, B., Bueno, M.A., Dadwal, S.S., Henry, M.W., Katragkou, A., Kontoyiannis, D.P., McCarthy, M.W., and Miller, A.O. (2022). Osteoarticular mycoses. Clin. Microbiol. Rev., 35.","DOI":"10.1128\/cmr.00086-19"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"van de Sande, W.W.J., Maghoub, E.S., Fahal, A.H., Goodfellow, M., Welsh, O., and Zijlstra, E. (2014). The mycetoma knowledge gap: Identification of research priorities. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002667"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"104285","DOI":"10.1016\/j.micpath.2020.104285","article-title":"RANK-RANKL signaling upregulates Il-10 mRNA expression in mucosal Candida infection in vivo","volume":"149","author":"Maeda","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Ahmed, Y.L., Gerke, J., Park, H.-S., Bayram, \u00d6., Neumann, P., Ni, M., Dickmanns, A., Kim, S.C., Yu, J.-H., and Braus, G.H. (2013). The velvet family of fungal regulators contains a DNA-binding domain structurally similar to NF-\u03baB. PLoS Biol., 11.","DOI":"10.1371\/journal.pbio.1001750"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6976.2011.00285.x","article-title":"Coordination of secondary metabolism and development in fungi: The velvet family of regulatory proteins","volume":"36","author":"Bayram","year":"2012","journal-title":"FEMS Microbiol. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/mmi.13275","article-title":"A phosphorylation code of the Aspergillus nidulans global regulator VelvetA (VeA) determines specific functions","volume":"99","author":"Rauscher","year":"2016","journal-title":"Mol. Microbiol."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Wang, P., Ma, L., Jin, J., Zheng, M., Pan, L., Zhao, Y., Sun, X., Liu, Y., and Xing, F. (2019). The anti-aflatoxigenic mechanism of cinnamaldehyde in Aspergillus flavus. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-47003-z"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Niu, A., Tan, L., Tan, S., Wang, G., and Qiu, W. (2023). The temporal dynamics of sensitivity, aflatoxin production, and oxidative stress of Aspergillus flavus in response to cinnamaldehyde vapor. Foods, 12.","DOI":"10.3390\/foods12234311"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Xiao, H., Zhang, Y., and Li, Q. (2025). 2-Hydroxy-4-methoxybenzaldehyde (HMB) disrupts ergosterol biosynthesis, redox metabolism, and DON biosynthesis of Fusarium graminearum revealed by transcriptome analysis. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1514170"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"15584","DOI":"10.3390\/molecules191015584","article-title":"Cellular transport mechanisms of cytotoxic metallodrugs: An overview beyond cisplatin","volume":"19","author":"Spreckelmeyer","year":"2014","journal-title":"Molecules"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/0127724328263050230923154326","article-title":"Glucose transporter and sensor mechanisms in fungal pathogens as potential drug targets","volume":"19","author":"Navale","year":"2024","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(86)90078-X","article-title":"Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions","volume":"35","author":"Snyder","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0006-2952(84)90178-3","article-title":"The effect of cyanide on the uptake of gold by red blood cells","volume":"33","author":"Graham","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"106582","DOI":"10.1016\/j.ijantimicag.2022.106582","article-title":"Repurposing non-antibiotic drugs auranofin and pentamidine in combination to combat multidrug-resistant Gram-negative bacteria","volume":"59","author":"Yu","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2023). Design and synthesis of novel antimicrobial agents. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030628"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Tang, M., Zhao, D., Liu, S., Zhang, X., Yao, Z., Chen, H., Zhou, C., Zhou, T., and Xu, C. (2023). The properties of linezolid, rifampicin, and vancomycin, as well as the mechanism of action of pentamidine, determine their synergy against Gram-negative bacteria. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813812"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/AAC.42.6.1309","article-title":"Treatment of infection due to Pneumocystis carinii","volume":"42","author":"Fishman","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2217\/fmb-2018-0070","article-title":"Pentamidine inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents","volume":"13","author":"Brilhante","year":"2018","journal-title":"Future Microbiol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1099\/jmm.0.000301","article-title":"In vitro synergistic combinations of pentamidine, polymyxin B, tigecycline and tobramycin with antifungal agents against Fusarium spp. J","volume":"65","author":"Venturini","year":"2016","journal-title":"Med. Microbiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/acsinfecdis.1c00466","article-title":"Structure-activity studies with bis-amidines that potentiate Gram-positive specific antibiotics against Gram-negative pathogens","volume":"7","author":"Wesseling","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1039\/D2MD00041E","article-title":"Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria","volume":"13","author":"Pugh","year":"2022","journal-title":"RSC Med. Chem."},{"key":"ref_187","first-page":"601","article-title":"Inhibitory properties of triethylphosphine goldlupinylsulfide in adjuvant-induced arthritis in rats","volume":"50","author":"Ghia","year":"1995","journal-title":"Farmaco"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"27862","DOI":"10.1021\/acsomega.3c02179","article-title":"Quinolizidine-type alkaloids: Chemodiversity, occurrence, and bioactivity","volume":"8","author":"Kato","year":"2023","journal-title":"ACS Omega"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acs.jmedchem.9b01436","article-title":"Distorted gold(I)-phosphine complexes as antifungal agents","volume":"63","author":"Dennis","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Cortat, Y., and Zobi, F. (2023). Resurgence and repurposing of antifungal azoles by transition metal coordination for drug discovery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15102398"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1039\/C8NJ01544A","article-title":"Metal-azole fungistatic drug complexes as anti-Sporothrix spp. agents","volume":"42","author":"Gagini","year":"2018","journal-title":"New. J. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1039\/D2DT00411A","article-title":"Clinically used antifungal azoles as ligands for gold(III) complexes: The influence of the Au(III) ion on the antimicrobial activity of the complex","volume":"51","author":"Kljun","year":"2022","journal-title":"Dalton Trans."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejmech.2018.01.065","article-title":"New insights in Au-NHCs complexes as anticancer agents","volume":"146","author":"Porchia","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Checconi, P., Mariconda, A., Catalano, A., Ceramella, J., Pellegrino, M., Aquaro, S., Sinicropi, M.S., and Longo, P. (2025). Searching for new gold(I)-based complexes as anticancer and\/or antiviral agents. Molecules, 30.","DOI":"10.3390\/molecules30081726"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Samanta, T., Roymahapatra, G., Porto, W.F., Seth, S., Ghorai, S., Saha, S., Sengupta, J., Franco, O.L., Dinda, J., and Mandal, S.M. (2013). N,N\u2019-Olefin functionalized bis-imidazolium gold(I) salt is an efficient candidate to control keratitis-associated eye infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058346"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/molecules15042203","article-title":"Gold(I) complexes of N-heterocyclic carbene ligands containing benzimidazole: Synthesis and antimicrobial activity","volume":"15","author":"Temelli","year":"2010","journal-title":"Molecules"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/jacsau.2c00308","article-title":"Metal complexes as antifungals? From a crowd-sourced compound library to the first in vivo experiments","volume":"2","author":"Frei","year":"2022","journal-title":"JACS Au"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Salmain, M., Gaschard, M., Baroud, M., Lepeltier, E., Jaouen, G., Passirani, C., and Vessi\u00e8res, A. (2023). Thioredoxin reductase and organometallic complexes: A pivotal system to tackle multidrug resistant tumors?. Cancers, 15.","DOI":"10.3390\/cancers15184448"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"117137","DOI":"10.1016\/j.ejmech.2024.117137","article-title":"Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR","volume":"283","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1021\/acs.jmedchem.4c02252","article-title":"Dual-targeting TrxR-EGFR alkynyl-Au(I) gefitinib complex induces ferroptosis in gefitinib-resistant lung cancer via degradation of GPX4","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Tharmalingam, N., Xu, S., Felix, L.O., Roy, B., Xian, M., Mylonakis, E., and Fuchs, B.B. (2023). Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase. Front. Antibiot., 2.","DOI":"10.3389\/frabi.2023.1179354"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0162-0134(87)80062-4","article-title":"Thiol competition for Et3PAuS-albumin: A nonenzymatic mechanism for Et3PO formation","volume":"30","author":"Coffer","year":"1987","journal-title":"J. Inorg. Biochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7909\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:28:58Z","timestamp":1760034538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":202,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26167909"],"URL":"https:\/\/doi.org\/10.3390\/ijms26167909","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}